StemSpan™-XF Xeno-Free Human Hematopoietic Cell Medium

总览

StemSpan™-XF专为体外培养和扩增人造血细胞而开发，可添加适当的生长因子和添加物。这使得用户可以根据实验需求灵活地配制培养基。StemSpan™-XF含有经过测试的人源性和重组人 (rh) 蛋白。

当搭配合适的StemSpan™扩增添加物，StemSpan™-XF可用于扩增从人脐带血、动员外周血或骨髓样本中分离的 CD34+细胞，或扩增和分化谱系定向祖细胞，从而生成红系、髓系或巨核细胞祖细胞群。

包含
This product contains only human-derived or recombinant human proteins.

亚型
专用培养基

细胞类型
造血干/祖细胞

种属
人

应用
细胞培养，扩增

品牌
StemSpan

研究领域
干细胞生物学，移植研究

制剂类别
无血清，Xeno-Free

查看更多显示更少

实验数据

Figure 1. Immunophenotyping of Cultured CD34⁺ Cells

Cord blood (CB)-derived CD34⁺ cells were purified using EasySep™ Human Cord Blood CD34 Positive Selection Kit II (Catalog #17896) and cultured in StemSpan™-XF (Catalog #100-0073) supplemented with StemSpan™ CD34⁺ Expansion Supplement (Catalog #02691) and UM171*. After 7 days, the cultured cells were stained with fluorescently labeled antibodies against CD34, CD90 and CD45RA, in addition to viability dye 7-AAD, and analyzed by flow cytometry. Sequential gates were used to determine the percentages of viable (A) CD34⁺ and CD34⁺CD90⁺CD45RA^- cells, based on fluorescence minus one (FMO) controls and (B) CD34^bright and CD34^brightCD90⁺CD45RA^- cells.

*Similar results are expected when using UM729 (Catalog #72332) prepared to a final concentration of 1μM. For more information including data comparing UM171 and UM729, see Fares et al. 2014.

Figure 2. StemSpan™ Media Support Greater Expansion of Human CD34⁺ and CD34^bright Cells Than Other Commercial Media

Purified CB-derived CD34⁺ cells were cultured for 7 days in StemSpan™ media (SFEM, SFEM II, AOF, and XF, orange bars), and in five media from other suppliers (Commercial Alternative, grey bars). All media were supplemented with StemSpan™ CD34⁺ Expansion Supplement and UM171*. The (A) frequency and (B) cell expansion of viable CD34⁺ and CD34^bright cells in culture were analyzed by flow cytometry as described in Figure 1. Compared to the commercial alternatives tested, StemSpan™ media showed significantly higher expansion of CD34⁺ and CD34^bright cells (P < 0.05 when comparing StemSpan™ SFEM, SFEM II, and XF to five media from other suppliers, calculated using a one-way ANOVA followed by Dunnett’s post hoc test). The CD34bright cell population is enriched for functional stem/progenitor cells (See Figure 4). Data shown are mean ± SEM (n = 8).

Note: Data for StemSpan™-AOF shown were generated with the original phenol red-containing version StemSpan™-ACF (Catalog #09855). However internal testing showed that the performance of the new phenol red-free, cGMP-manufactured version, StemSpan™-AOF (Catalog #100-0130) was comparable.

*Similar results are expected when using UM729 (Catalog #72332) prepared to a final concentration of 1μM. For more information including data comparing UM171 and UM729, see Fares et al. 2014.

Figure 3. StemSpan™ Media Support Equal or Greater Expansion of Primitive Human CD34^brightCD90⁺CD45RA^- Cells Than Other Commercial Media

Purified CB-derived CD34⁺ cells were cultured for 7 days in StemSpan™ media (SFEM, SFEM II, AOF, and XF, orange bars), and in five media from other suppliers (Commercial Alternative, grey bars). All media were supplemented with StemSpan™ CD34⁺ Expansion Supplement and UM171*. The (A) frequency and (B) cell expansion of viable CD34⁺CD90⁺CD45RA^- (solid) and CD34^brightCD90⁺CD45RA^- (dotted overlay) cells in culture were analyzed by flow cytometry as described in Figure 1. Compared to the commercial alternatives tested, StemSpan™ media showed similar or significantly higher expansion of CD34^brightCD90⁺CD45RA^- cells (P < 0.05 when comparing StemSpan™ SFEM II and XF to five media from other suppliers, calculated using one-way ANOVA followed by Dunnett’s post hoc test). The CD34^brightCD90⁺CD45RA^- cell population is highly enriched for functional stem/progenitor cells (See Figure 4). Data shown are mean ± SEM (n = 8).

Note: Data for StemSpan™-AOF shown were generated with the original phenol red-containing version StemSpan™-ACF (Catalog #09855). However internal testing showed that the performance of the new phenol red-free, cGMP-manufactured version, StemSpan™-AOF (Catalog #100-0130) was comparable.

*Similar results are expected when using UM729 (Catalog #72332) prepared to a final concentration of 1μM. For more information including data comparing UM171 and UM729, see Fares et al. 2014.

Figure 4. Culture-Expanded CD34^bright Cells Have Higher Colony-Forming Potential Than Culture-Expanded CD34^med and CD34^- Cells

Purified CB-derived CD34⁺ cells (n = 2) were cultured in StemSpan™-XF with StemSpan™ CD34⁺ Expansion Supplement and UM171* for 7 days. Cultured cells were stained with an anti-CD34 antibody and 7-AAD for sorting. Anti-CD90, and CD45RA antibodies were also included, to be used in later analyses. Cells were either (A) bulk-sorted or (B,C) single cell index-sorted from CD34^bright, CD34^med, and CD34^- populations. Sorted cells were plated in colony-forming unit (CFU) assays using MethoCult™ H4034 Optimum (Catalog #04034). (A) Bulk-sorted cells were plated at 400 cells/mL in 6-well SmartDish™ plates (Catalog #27370) and (B,C) single cells were sorted directly into 96-well plates (one cell per well, prefilled with 100 µL of MethoCult™). After 14 days of incubation, colonies were counted with (A) STEMvision™ or (B,C) manually using an inverted microscope. (A) Shown are representative images of CFU assays from bulk-sorted cells of CD34^bright, CD34^med, and CD34^- populations. The frequency of colonies in each population from the single cell-sorted experiments are shown as (B) CFU frequency, calculated as the total number of colonies generated by the total number of individually sorted cells (shown respectively as a fraction above each bar), and (C) CFU output expressed as total numbers of CFU in each sorted population per original input CD34⁺ cell.

The culture-expanded CD34^bright cells showed (B) higher CFU frequency (~50%) than CD34^med cells (~20%) and CD34^- cells (~10%), and yielded more diverse and primitive colony types, including CFU-GEMM and BFU-E colonies, which were rarely generated from CD34^med and CD34^- cells. When phenotyping data, collected during sorting, was analyzed all CFU-GEMM and the majority of of BFU-E colonies were generated from the fraction enriched for LT-HSCs, the CD34^brightCD90⁺CD45RA^- cell population, while 33% of BFU-E colonies were generated from the fraction enriched for ST-HSCs, the CD34^brightCD90-CD45RA- cell population. Only small CFU-G and CFU-M colonies were generated from CD34^brightCD90^+/-CD45RA⁺ cells, which is consistent with publications suggesting this population contains only progenitor cells.

*Similar results are expected when using UM729 (Catalog #72332) prepared to a final concentration of 1μM. For more information including data comparing UM171 and UM729, see Fares et al. 2014.